BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22405851)

  • 21. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.
    Rossi M; Demidov ON; Anderson CW; Appella E; Mazur SJ
    Nucleic Acids Res; 2008 Dec; 36(22):7168-80. PubMed ID: 19015127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio.
    Goloudina AR; Mazur SJ; Appella E; Garrido C; Demidov ON
    Cell Cycle; 2012 May; 11(10):1883-7. PubMed ID: 22544321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WIP1 phosphatase at the crossroads of cancer and aging.
    Le Guezennec X; Bulavin DV
    Trends Biochem Sci; 2010 Feb; 35(2):109-14. PubMed ID: 19879149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D.
    Castellino RC; De Bortoli M; Lu X; Moon SH; Nguyen TA; Shepard MA; Rao PH; Donehower LA; Kim JY
    J Neurooncol; 2008 Feb; 86(3):245-56. PubMed ID: 17932621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.
    Zhang M; Xu E; Zhang J; Chen X
    Oncogene; 2015 Nov; 34(48):5900-11. PubMed ID: 25823026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wip1 regulates the generation of new neural cells in the adult olfactory bulb through p53-dependent cell cycle control.
    Zhu YH; Zhang CW; Lu L; Demidov ON; Sun L; Yang L; Bulavin DV; Xiao ZC
    Stem Cells; 2009 Jun; 27(6):1433-42. PubMed ID: 19489034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Wip1 phosphatase and Mdm2: cracking the "Wip" on p53 stability.
    Lu X; Nguyen TA; Zhang X; Donehower LA
    Cell Cycle; 2008 Jan; 7(2):164-8. PubMed ID: 18333294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The modulation of the oxidative stress response in chondrocytes by Wip1 and its effect on senescence and dedifferentiation during in vitro expansion.
    Cha BH; Lee JS; Kim SW; Cha HJ; Lee SH
    Biomaterials; 2013 Mar; 34(9):2380-8. PubMed ID: 23306038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin.
    Zhang L; Liu L; He Z; Li G; Liu J; Song Z; Jin H; Rudolph KL; Yang H; Mao Y; Zhang L; Zhang H; Xiao Z; Ju Z
    Hepatology; 2015 Jun; 61(6):2030-41. PubMed ID: 25704606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
    Long X; Lin XJ
    J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.
    Crescenzi E; Raia Z; Pacifico F; Mellone S; Moscato F; Palumbo G; Leonardi A
    J Biol Chem; 2013 Jun; 288(23):16212-16224. PubMed ID: 23612976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.
    Zajkowicz A; Butkiewicz D; Drosik A; Giglok M; Suwiński R; Rusin M
    Br J Cancer; 2015 Mar; 112(6):1114-20. PubMed ID: 25742468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
    Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
    Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of dysregulated Wip1 in manganese-induced p53 signaling and neuronal apoptosis.
    Ma X; Han J; Wu Q; Liu H; Shi S; Wang C; Wang Y; Xiao J; Zhao J; Jiang J; Wan C
    Toxicol Lett; 2015 May; 235(1):17-27. PubMed ID: 25791630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPM1D regulates p21 expression via dephoshporylation at serine 123.
    Cao R; Zhang J; Zhang M; Chen X
    Cell Cycle; 2015; 14(4):641-7. PubMed ID: 25590690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage.
    Dayaram T; Lemoine FJ; Donehower LA; Marriott SJ
    PLoS One; 2013; 8(2):e55989. PubMed ID: 23405243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung.
    Rahman M; Lovat F; Romano G; Calore F; Acunzo M; Bell EH; Nana-Sinkam P
    J Biol Chem; 2014 Sep; 289(38):26406-26416. PubMed ID: 25092292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint.
    Kleiblova P; Shaltiel IA; Benada J; Ševčík J; Pecháčková S; Pohlreich P; Voest EE; Dundr P; Bartek J; Kleibl Z; Medema RH; Macurek L
    J Cell Biol; 2013 May; 201(4):511-21. PubMed ID: 23649806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner.
    Fiscella M; Zhang H; Fan S; Sakaguchi K; Shen S; Mercer WE; Vande Woude GF; O'Connor PM; Appella E
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6048-53. PubMed ID: 9177166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibition of WIP1 in A549 cells enhances the sensitivity of cells to arsenic treatment].
    Luo Q; Gu S; Zhang Z
    Wei Sheng Yan Jiu; 2017 May; 46(3):389-395. PubMed ID: 29903248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.